Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.co.in
Google Alert - tezepelumab
Get the latest updates from Google Alert - tezepelumab directly as they happen.
Follow now 112 followers
Latest posts
Last updated 37 minutes ago
Tezepelumab Shows Promise for Severe Asthma Patients - BIOENGINEER.ORG
about 4 hours ago
Tezepelumab operates at the very beginning of the inflammatory chain, which may...
Three Biologic-Naïve Patients with Allergic Bronchopulmonary Aspergillosis Showing ...
about 7 hours ago
Tezepelumab is a monoclonal antibody against thymic stromal lymphopoietin (TSLP), which plays...
Tezspire: nuevo tratamiento de AstraZeneca para asma grave que reduce las ... - El Digital Panamá
1 day ago
En un avance clave para el manejo del asma grave, AstraZeneca lanza...
Tezspire: nuevo tratamiento de AstraZeneca para el asma grave reduce ... - Panama 24 Horas
1 day ago
Tezspire (Tezepelumab) ofrece control preventivo del asma grave y mejora la calidad...
Tezepelumab Reduces Exacerbations and Improves Quality of Life in Severe Asthma - EMJ
2 days ago
The DIRECTION study aimed to evaluate the efficacy and safety of tezepelumab...
Tezepelumab (Tezspire) - svær kronisk rhinosinuitis med næsepolypper (CRSwNP)
2 days ago
Tezepelumab (Tezspire) · Beslutning om anbefaling · Sagsbehandlingstid · Beslutning om indplacering...
轩竹生物与先声药业新一代ALK抑制剂获批上市，开创国内治疗新时代 - 新药情报库- 智慧芽
3 days ago
点击本文中加粗蓝色字体即可一键直达新药情报库免费查阅文章里提到的药物、机构、靶点、适应症的最新研发进展。 8月22日，国家药品监督管理局（NMPA）官方网站 ...
AstraZeneca's Tezepelumab Study: A New Hope for Chronic Rhinosinusitis Treatment
4 days ago
... Tezepelumab (ESSENCE)'. The study aims to evaluate the treatment outcomes of...
De Corso (Euforea): "Tezepelumab riduce dimensione polipi e sintomi" - MSN
5 days ago
Tezepelumab si aggiunge ai farmaci biologici già disponibili e, come evidenzia lo...
Astrazeneca Shares Rise 0.63% on 42.73% Volume Surge to Rank 368th as Clinical Trials ...
6 days ago
- Analysts note AZD8630's potential to strengthen pediatric asthma leadership and Tezepelumab's...
阿法纳生物带状疱疹mRNA疫苗Ⅰ期临床试验正式启动 - 新药情报库
6 days ago
2025年8月22日，合肥阿法纳生物科技有限公司（下称“阿法纳”）自主研发的带状疱疹mRNA疫苗Ⅰ期临床试验启动会在广西顺利召开。这次会议的成功举行，标志着阿法纳在 ...
AstraZeneca's New Study on Tezepelumab for CRSwNP: A Potential Game-Changer
6 days ago
The intervention being tested is Tezepelumab, a combination product administered as a...